Proof of Concept Evaluation of Drug-Device Interaction With Aclidinium Bromide Via Genuair and Tiotropium Bromide Via HandiHaler in COPD Using Impulse Oscillometry

Trial Profile

Proof of Concept Evaluation of Drug-Device Interaction With Aclidinium Bromide Via Genuair and Tiotropium Bromide Via HandiHaler in COPD Using Impulse Oscillometry

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Aclidinium bromide (Primary) ; Tiotropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Proof of concept; Therapeutic Use
  • Acronyms MAN04
  • Most Recent Events

    • 13 Nov 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 04 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 may 2015 as reported by ClinicalTrials.gov record.
    • 04 Mar 2015 Planned primary completion date changed from 1 Dec 2014 to 1 may 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top